Skip to content
Beacon

BISProShares UltraShort Nasdaq Biotechnology

Take a bet#421 of 761 for Take a bet

Seeks daily investment results of -200% of the daily performance of the Nasdaq Biotechnology Index.

ProShares · Since 2010 (16 years)

Annual Cost

0.95%

#4471 out of 5,332 ETFs

Fund Size

$2M

#5070 out of 5,332 ETFs

Dividend Yield

4.92%

Track Record

16 years

#783 out of 5,332 ETFs

Performance

1 Year

-48.5%

3 Years

-21.2%

5 Years

-13.4%

What's inside

Asset class
Strategy
inverse
Cap
multi cap

Asset allocation

Cash
199.9%
Other
100.0%

Risk profile

Volatility (1Y)

41.9%

High

Max drawdown

-95.2%

Worst peak-to-trough loss

Sharpe (3Y)

-0.50

Below average

Sortino (3Y)

-0.70

Moderate downside risk

Similar ETFs

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Inverse
Warning

Inverse ETF — daily tool only

Delivers the inverse of the benchmark's daily return. The compounding path makes multi-day holding unpredictable even when the benchmark's total move goes your way. Legitimate as a one-day hedge; dangerous as a view.

Source: Cheng & Madhavan (2009)

Why we flagged this: strategy=inverse + inverse_name_or_strategy

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

Data updated on 2026-05-05